Neoadjuvant Chemo New SOC Option in Urothelial Carcinoma Neoadjuvant Chemo New SOC Option in Urothelial Carcinoma
Neoadjuvant chemotherapy in the high-risk population demonstrated favorable pathologic responses, and was well tolerated.Medscape Medical News
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Hematology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Surgery